Skip to main content

Advertisement

Log in

Updated panel report: best practices for the surgical treatment of obesity

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

During the 2004 annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), a panel of experts convened to provide updated information on best practices in bariatric surgery. The rapid evolution of endoluminal technologies, surgical indications, and training in bariatric surgery since 2004 has led to new questions and concerns about optimal treatment algorithms, patient selection, and the preparation of our current and future bariatric workforce.

Methods

An expert panel was convened at the SAGES 2017 annual meeting to provide a summative update on current practice patterns, techniques, and training in bariatric surgery in order to review and establish best practices. This was a joint effort by SAGES, International Society for the Perioperative Care of the Obese Patient, and the American Society for Metabolic and Bariatric Surgery.

Results

On March 23, 2017, seven expert faculty convened to address current areas of controversy in bariatric surgery and provide updated guidelines and practice recommendations. Areas addressed included the expanded indications for use of metabolic surgery in the treatment of diabetes, the safety and efficacy of new and investigational endoluminal procedures, updates on new guidelines for the management of airway and sleep apnea in the obese patient, the development of clinical pathways to reduce variation in the management of the bariatric patient, and new guidelines for training, credentialing, and bariatric program accreditation. The following article is a summary of this panel.

Conclusion

Bariatric surgery is a field that continues to evolve. A timely, systematic approach, such as described here, that coalesces data and establishes best practices on the current body of available evidence is imperative for optimal patient care and to inform provider, insurer, and policy decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jones DB, DeMaria E, Provost DA, Smith CD, Morgenstern L, Schirmer B (2004) Optimal management of the morbidly obese patient: SAGES appropriateness conference statement. Surg Endosc 18(7):1029–1037

    Article  CAS  Google Scholar 

  2. Mechanick JI, Youdim A, Jones DB et al (2013) Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update; cosponsored by the American Association of Clinical Endocrinologists, the Obesity Society, and the American Society for Metabolic and Bariatric Surgery. SOARD 9:159–191 (Concurrently published Obesity 21:S1–S27, 2013, and Endocrine Practice 2013)

    Google Scholar 

  3. Jones SB, Jones DB (2009) Obesity surgery: patient safety and best practices. Cine-Med Inc., Woodbury

    Google Scholar 

  4. Lim R, Blackburn G, Jones DB (2010) Benchmarking best practices in weight loss surgery. Curr Probl Surg 47(2):69–174

    Google Scholar 

  5. Schirmer B, Jones DB (2007) American College of Surgeons Bariatric Surgery Center Network: establishing standards. Bull Am Coll Surg 92(8):21–27

    PubMed  Google Scholar 

  6. Rubino F, Nathan DM, Schauer PR et al (2016) Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 39(6):861–877

    Article  CAS  Google Scholar 

  7. Mingrone G, Panunzi S, De Gaetano A et al (2015) Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386(9997):964–973

    Article  Google Scholar 

  8. Schauer PR, Bhatt DL, Kirwan JP, STAMPEDE Investigators et al (2017) Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 376(7):641–651

    Article  Google Scholar 

  9. American Diabetes Association (2017) Obesity management for the treatment of type 2 diabetes. Diabetes Care 40(1):S57–S63

    Article  Google Scholar 

  10. Zheng Y, Wang M, He S, Ji G (2015) Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. J Transl Med 13:246

    Article  Google Scholar 

  11. Thompson CC, Abu Dayyeh BK, Kushner R et al (2017) Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol 112(3):447–457

    Article  Google Scholar 

  12. Brethauer SA, Chand B, Schauer PR, Thompson CC (2012) Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis 8(3):296–303

    Article  Google Scholar 

  13. Lopez-Nava G, Galvao M, Bautista-Castaño I, Fernandez-Corbelle JP, Trell M (2016) Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open 4(2):E222–E227

    Article  CAS  Google Scholar 

  14. Sullivan S, Swain JM, Woodman G, Antonetti M et al (2017) Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity (Silver Spring) 25(2):294–301

    Article  Google Scholar 

  15. Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK (2016) Effect of the endobarrier gastrointestinal liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 18(3):300–305

    Article  CAS  Google Scholar 

  16. Rajagopalan H, Cherrington AD, Thompson CC, Kaplan LM et al (2016) Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care 39(12):2254–2261

    Article  CAS  Google Scholar 

  17. Peterson G, Domino K, Caplan RA, Posner KL, Lee LA et al (2005) Management of the difficult airway: a closed claims analysis. Anesthesiology 103:33–39

    Article  Google Scholar 

  18. Apfelbaum JL, Hagberg CA, Caplan RA, Connis RT, American Society of Anesthesiologists Task Force on Management of the Difficult Airway et al (2013) Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 118(2):251–270

    Article  Google Scholar 

  19. Frerk C, Mitchell VS, McNarry AF, Bhagrath R et al (2015) Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth 115(6):827–848

    Article  CAS  Google Scholar 

  20. American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep Apnea (2014) Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 120(2):268–286

    Article  Google Scholar 

  21. Chung F, Memtsoudis SG, Ramachandran SK et al (2016) Society of anesthesia and sleep medicine guidelines on preoperative screening and assessment of adult patients with obstructive sleep apnea. Anesth Analg 123(2):452–473

    Article  Google Scholar 

  22. Panella M, Marchisio S, Di Stanislao F (2003) Reducing clinical variations with clinical pathways: do pathways work? Int J Qual Health Care 15:509–521

    Article  CAS  Google Scholar 

  23. Rotter T, Kugler J, Koch R et al (2008) A systematic review and meta-analysis of the effects of clinical pathways on length of stay, hospital costs and patient outcomes. BMC Health Serv Res 8:265

    Article  Google Scholar 

  24. Campillo-Soto A, Martín-Lorenzo JG, Lirón-Ruíz R et al (2008) Evaluation of the clinical pathway for laparoscopic bariatric surgery. Obes Surg 18:395–400

    Article  Google Scholar 

  25. Huerta S, Heber D, Sawicki MP et al (2001) Reduced length of stay by implementation of a clinical pathway for bariatric surgery in an academic health care center. Am Surg 67:1128–1135

    CAS  PubMed  Google Scholar 

  26. Yeats M, Wedergren S, Fox N, Thompson JS (2005) The use and modification of clinical pathways to achieve specific outcomes in bariatric surgery. Am Surg 71:152–154

    PubMed  Google Scholar 

  27. Frutos MD, Luján J, Hernández Q, Valero G, Parrilla P (2007) Clinical pathway for laparoscopic gastric bypass. Obes Surg 17:1584–1587

    Article  Google Scholar 

  28. Ronellenfitsch U, Schwarzbach M, Kring A, Kienle P, Post S, Hasenberg T (2012) The effect of clinical pathways for bariatric surgery on perioperative quality of care. Obes Surg 22:732–739

    Article  Google Scholar 

  29. Standards Manual V2.0 (2016) Resource for optimal care of the bariatric surgery patient. American College of Surgeons, Chicago

    Google Scholar 

  30. Telem DA, Majid SF, Powers K, DeMaria E, Morton J, Jones DB (2017) Assessing national provision of care: variability in bariatric clinical care pathways. Surg Obes Relat Dis 13:281–284

    Article  Google Scholar 

  31. Telem DA, Gould J, Pesta C, Powers K, Majid S, Greenberg JA, Teixeira A, Brounts L, Lin H, DeMaria E, Rosenthal R (2017) American Society for Metabolic and Bariatric Surgery: care pathway for laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 13(5):742–749

    Article  Google Scholar 

  32. McBride CL, Rosenthal RJ, Brethauer S, DeMaria E et al (2017) Constructing a competency-based bariatric surgery fellowship training curriculum. Surg Obes Relat Dis 13(3):437–441

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dana A. Telem.

Ethics declarations

Disclosures

Dr. Schauer has the following relationships: (1) Advisory Board: The Medicines Company, GI Dynamics, Neurotronic, Pacira; (2) Consultant: Ethicon, The Medicines Company, Novo Nordisk; (3) Research Support: Ethicon, National Institutes of Health, Medtronic, Pacira. Dr. Rosenthal has the following relationships: (1) Speaker, Medtronic. Dr. Daniel Jones: (1) Allurion Gastric Ballon. Dr. Dana Telem: (1) Consultant, Medtronic. Otherwise, the rest of the authors have no conflict of interest and nothing to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Telem, D.A., Jones, D.B., Schauer, P.R. et al. Updated panel report: best practices for the surgical treatment of obesity. Surg Endosc 32, 4158–4164 (2018). https://doi.org/10.1007/s00464-018-6160-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-018-6160-x

Keywords

Navigation